세계의 미생물 동정 시장 : 제품 및 서비스, 수법, 기술, 용도, 최종 사용자별 예측(2025-2030년)

The Microbial Identification Market was valued at USD 4.44 billion in 2023, expected to reach USD 4.96 billion in 2024, and is projected to grow at a CAGR of 12.08%, to USD 9.88 billion by 2030.

The microbial identification market encompasses technologies and methodologies used to determine and classify microorganisms, with applications spanning healthcare, pharmaceuticals, food and beverage, water treatment, and environmental monitoring. It is crucial for diagnosing infectious diseases, ensuring food safety, and maintaining environmental hygiene. End-use sectors, such as hospitals, laboratories, and manufacturing units, rely on microbial identification to ensure product quality and compliance with regulatory standards. Market growth is propelled by advancements in technology, such as next-generation sequencing and rapid pathogen identification methods, as well as increasing demands for systematic disease management and growing awareness of antimicrobial resistance. The healthcare sector is particularly influential, driven by the need for accurate and timely identification of pathogens to guide appropriate treatment plans.

Recent trends indicate an uptick in demand for automated identification systems and bioinformatics tools, providing lucrative opportunities for industry players to develop integrated solutions combining convenience with high precision. The globalization of trade also poses challenges with complex regulatory environments and the need for standardized methods across different regions, though it simultaneously opens up new markets. Barriers include high equipment costs, the need for skilled personnel, and adoption barriers in low-income regions where resources are limited.

Research and innovation should focus on developing cost-effective, user-friendly, and portable identification systems suitable for remote locations. Capitalizing on artificial intelligence and machine learning to improve identification speed and accuracy can provide competitive edges. Furthermore, expanding the scope of applications beyond traditional fields into areas like cosmetics and agriculture could fuel growth. The market is dynamic with periodic shifts influenced by technological innovations and public health needs, necessitating continuous adaptation and strategic investments to remain competitive. Companies should focus on collaborations and partnerships with academic research institutes to stay at the forefront of innovation and leverage emerging technologies for substantial market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microbial Identification Market

The Microbial Identification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government policies and financial support for microbial identification
  • Rising prevalence of infectious diseases and threats of pandemics
  • Increasing challenges and concerns regarding food safety
• Market Restraints
  • High cost associated with the microbial identification process
• Market Opportunities
  • Rising efforts toward bioterrorism surveillance
  • Ongoing advancements in molecular biology techniques and bioinformatics
• Market Challenges
  • Limitations of traditional microbial testing with complexities in regulatory standards across different regions

Porter's Five Forces: A Strategic Tool for Navigating the Microbial Identification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microbial Identification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microbial Identification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microbial Identification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microbial Identification Market

A detailed market share analysis in the Microbial Identification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microbial Identification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microbial Identification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Microbial Identification Market

A strategic analysis of the Microbial Identification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Microbial Identification Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Beckman Coulter, Inc., Becton, Dickinson and Company, Biolog, Inc., bioMerieux SA, Bruker Corporation, Charles River Laboratories International, Inc., Creative Diagnostics, DH Life Sciences, LLC, Eurofins Scientific (Ireland) Limited, Genefluidics, Inc., Gradian Diagnostics, Himedia Laboratories, i2a, Liofilchem S.R.L., Merck KGaA, Metabolon Inc., QIAGEN GmbH, Shimadzu Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, VWR International, LLC. by Avantor, Inc., Wickham Micro Ltd., and Zhuhai DL Biotech. Co.,LTD..

Market Segmentation & Coverage

This research report categorizes the Microbial Identification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Consumables, Instruments, and Services.
• Based on Method, market is studied across Genotypic Method, Phenotypic Method, and Proteomic-Based Method.
• Based on Technology, market is studied across Flow Cytometry, Mass Spectrometry, Microscopy, and Polymerase Chain Reaction (PCR).
• Based on Application, market is studied across Cosmetics & Personal Care Products Testing, Diagnostic, Environmental Applications, Food & Beverage Testing, and Pharmaceutical Testing.
• Based on End-user, market is studied across Food & Beverage Manufacturing Companies, Hospitals & Diagnostic Laboratories, and Pharmaceutical Manufacturers & CROs.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government policies and financial support for microbial identification
    • 5.1.1.2. Rising prevalence of infectious diseases and threats of pandemics
    • 5.1.1.3. Increasing challenges and concerns regarding food safety
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the microbial identification process
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising efforts toward bioterrorism surveillance
    • 5.1.3.2. Ongoing advancements in molecular biology techniques and bioinformatics
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations of traditional microbial testing with complexities in regulatory standards across different regions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product & Service: Proliferating utilization of instruments to facilitate identification of microorganisms at species and strain level
  • 5.2.2. Application: Evolving utilization of microbial identification in pharmaceutical testing
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Microbial Identification Market, by Product & Service

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments
• 6.4. Services

7. Microbial Identification Market, by Method

• 7.1. Introduction
• 7.2. Genotypic Method
• 7.3. Phenotypic Method
• 7.4. Proteomic-Based Method

8. Microbial Identification Market, by Technology

• 8.1. Introduction
• 8.2. Flow Cytometry
• 8.3. Mass Spectrometry
• 8.4. Microscopy
• 8.5. Polymerase Chain Reaction (PCR)

9. Microbial Identification Market, by Application

• 9.1. Introduction
• 9.2. Cosmetics & Personal Care Products Testing
• 9.3. Diagnostic
• 9.4. Environmental Applications
• 9.5. Food & Beverage Testing
• 9.6. Pharmaceutical Testing

10. Microbial Identification Market, by End-user

• 10.1. Introduction
• 10.2. Food & Beverage Manufacturing Companies
• 10.3. Hospitals & Diagnostic Laboratories
• 10.4. Pharmaceutical Manufacturers & CROs

11. Americas Microbial Identification Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Microbial Identification Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Microbial Identification Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. bioMerieux and FDA Partner to Enhance Food Safety and Combat Pathogens
  • 14.3.2. Tentamus Pharma UK Enhances Microbial Identification with Advanced MALDI-TOF Mass Spectrometer
  • 14.3.3. HiMedia & NG Biotech Launch AMR Bacteria Detection Kits in India
  • 14.3.4. Wickham Micro Doubles Capacity for MALDI-ToF Microbial Identification Service
  • 14.3.5. Biolog Adds Contract Microbial Service Capabilities Through MIDI Labs Buyout
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accelerate Diagnostics, Inc.
• 2. Alifax S.r.l.
• 3. Beckman Coulter, Inc.
• 4. Becton, Dickinson and Company
• 5. Biolog, Inc.
• 6. bioMerieux SA
• 7. Bruker Corporation
• 8. Charles River Laboratories International, Inc.
• 9. Creative Diagnostics
• 10. DH Life Sciences, LLC
• 11. Eurofins Scientific (Ireland) Limited
• 12. Genefluidics, Inc.
• 13. Gradian Diagnostics
• 14. Himedia Laboratories
• 15. i2a
• 16. Liofilchem S.R.L.
• 17. Merck KGaA
• 18. Metabolon Inc.
• 19. QIAGEN GmbH
• 20. Shimadzu Corporation
• 21. Thermo Fisher Scientific Inc.
• 22. Trivitron Healthcare
• 23. VWR International, LLC. by Avantor, Inc.
• 24. Wickham Micro Ltd.
• 25. Zhuhai DL Biotech. Co.,LTD.